Activation of Innate Immunity Effector Cells
先天免疫效应细胞的激活
基本信息
- 批准号:6838210
- 负责人:
- 金额:$ 35.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-07-01 至 2007-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
EXCEED THE SPACE PROVIDED. Our long term goal is to understand how developing immune responses are regulated by effector cells of innate immunity. NK cells play a primary role in this regulation, and our preliminary data suggest that their physiological role(s) depend on their developmental stage, with immature and mature NK cells likely primarily involved, respectively, in maintaining non-adaptive immunity, and in regulating the development of adaptive responses. We have defined that immature CD161+CD56 - NK cells have highest proliferative potential in response to interleukin (IL)-4, can not mediate granule exocytosis-dependent cytotoxicity and produce cytokines that primarily affect myeloid and B cells [i.e. tumor necrosis factor (TNF)-ct, Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF), and the type 2 cytokines interleukin (IL)-5 and IL-13]. These cells, present in the periphery, develop, transiting through an IL-13+Interferon (IFN)-_ stage, into terminally differentiated, phenotypically mature CD56 + cells that exert granule exocytosis- and Fas-ligand (L)-mediated cytotoxicity, have decreased ability to produce TNF-o_ and GM-CSF, are IL-13-, and produce exclusively IFN-y, and finally IL-10 as they undergo apoptotic cell death. This poses the basis for our working hypothesis that qualitative modulation of peripheral NK cell functions is achieved primarily via modulation of the terminal linear development of the immature peripheral NK cells by any factor (cytokine or cellular interaction) that retards it by inducing their proliferation-dependent accumulation, or accelerates it by inducing changes that allow the cells to respond to IL-12 and other yet-to-be defined differentiation-inducing stimuli. Our additional observation that this developmental process is shared with T cells leads us to predict that the same cytokines may regulate it both T and NK cells, and that one or more receptor(s) involved in target cell recognition in NK cells may share with the TCR functions other than ligand recognition. This working hypothesis will be tested in 3 Specific Aims: 1) To determine the role of IFN and other selected cytokines in terminal NK cell development; 2) To define the regulation and function (other than cytotoxicity) of "activating" receptors on NK cells; 3) To analyze the possibility that NK cells derive from a common (type 2 cytokine +) peripheral T/NK cell progenitor cell. The results of these studies are expected to pose the bases for rational manipulation of the innate system for cytokine-based and/or immunotherapeutic and preventive interventions (e.g. vaccinations to pathogens like viruses and tumors). Also, defining how immature peripheral cells, present in any individual, can be maintained and/or induced to differentiate to functionally mature lymphocytes is relevant to the possibility of genetic manipulation of innate immunity and its reconstitution in numerous clinical settings. PERFORMANCE SITE ========================================Section End===========================================
超过提供的空间。我们的长期目标是了解开发免疫反应如何受到先天免疫的效应细胞的调节。 NK细胞在该调节中起主要作用,我们的初步数据表明它们的生理作用取决于它们的发育阶段,未成熟和成熟的NK细胞可能分别主要参与维持非自适应免疫性,并在调节适应性反应的发展中。我们已经确定,未成熟的CD161+CD56-NK细胞在响应白介素(IL)-4的响应中具有最高的增殖潜力,无法介导颗粒胞吐依赖性细胞毒性,并产生主要影响髓样和B细胞的细胞因子[即。肿瘤坏死因子(TNF)-CT,粒细胞 - 巨噬细胞刺激因子(GM-CSF)以及2型细胞因子白介素(IL)-5和IL-13]。 These cells, present in the periphery, develop, transiting through an IL-13+Interferon (IFN)-_ stage, into terminally differentiated, phenotypically mature CD56 + cells that exert granule exocytosis- and Fas-ligand (L)-mediated cytotoxicity, have decreased ability to produce TNF-o_ and GM-CSF, are IL-13-, and produce exclusively IFN-y, and最后,IL-10在发生凋亡细胞死亡时。这为我们的工作假设奠定了基础,即外围NK细胞功能的定性调节主要是通过通过任何因素(细胞因子或细胞相互作用)(细胞因子或细胞相互作用)来调节未成熟外周外围NK细胞的终末线性发育来实现的,从而通过其诱导其依赖于增殖的细胞来诱导其依赖的细胞和加速响应的任何因素(细胞因子或细胞相互作用)来诱导其疾病,或者允许其变化。12诱导刺激。我们对这种发育过程与T细胞共享的其他观察结果使我们预测相同的细胞因子可以调节其T和NK细胞,并且在NK细胞中参与靶细胞识别的一个或多个受体可能与配体识别以外的TCR功能共享。该工作假设将在3个特定目的中进行测试:1)确定IFN和其他选定的细胞因子在末端NK细胞发育中的作用; 2)定义NK细胞上“激活”受体的调节和功能(除细胞毒性之外); 3)分析NK细胞从常见(2型细胞因子 +)周围T/NK细胞祖细胞衍生而来的可能性。这些研究的结果有望为基于细胞因子和/或免疫治疗和预防性干预措施的先天系统合理操纵(例如,对病毒和肿瘤等病原体的疫苗接种)构成基础。同样,定义任何个体中存在的不成熟的外围细胞如何保持和/或诱导以区分功能成熟的淋巴细胞与在众多临床环境中对先天免疫及其重新建立的基因操纵的可能性有关。表演站点=============================================================================================
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BICE PERUSSIA其他文献
BICE PERUSSIA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BICE PERUSSIA', 18)}}的其他基金
FLOW CYTOMETRY FACILITY HIGH SPEED SORTER: LEUKEMIA
流式细胞术设备高速分选机:白血病
- 批准号:
7166527 - 财政年份:2005
- 资助金额:
$ 35.33万 - 项目类别:
FLOW CYTOMETRY FACILITY HIGH SPEED SORTER: AIDS
流式细胞术设备高速分选机:艾滋病
- 批准号:
7166526 - 财政年份:2005
- 资助金额:
$ 35.33万 - 项目类别:
FLOW CYTOMETRY FACILITY HIGH SPEED SORTER: IMMUNOLOGY
流式细胞术设备高速分选机:免疫学
- 批准号:
7166528 - 财政年份:2005
- 资助金额:
$ 35.33万 - 项目类别:
ACTIVATION OF NON-MHC-RESTRICTED CYTOTOXIC LYMPHOCYTES
非 MHC 限制性细胞毒性淋巴细胞的激活
- 批准号:
2091818 - 财政年份:1987
- 资助金额:
$ 35.33万 - 项目类别:
相似国自然基金
CXORF40A/B 协同 TUFM 抑制先天免疫激活的分子机制探究
- 批准号:82301971
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
病毒激活先天免疫TLR通路参与系统性红斑狼疮继发免疫性血小板减少的机制研究
- 批准号:82302054
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
靶向激活Nur77调控猪肠道ILC3可塑性促进肠道先天免疫成熟的机制
- 批准号:32372920
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
共激活先天和适应性免疫的乏氧响应脂质体药物构建及其增强三阴乳腺癌立体定向放疗效果和远隔效应的研究
- 批准号:82372123
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
草鱼CD11b识别脂多糖激活先天免疫的分子机制研究
- 批准号:32303049
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Therapeutic targeting of CD206+ TAMs to enhance adaptive and innate anti-tumor immune responses in metastatic castration-resistant prostate cancer
CD206 TAM 的治疗靶向增强转移性去势抵抗性前列腺癌的适应性和先天抗肿瘤免疫反应
- 批准号:
10731906 - 财政年份:2023
- 资助金额:
$ 35.33万 - 项目类别:
Mechanisms of antiviral immunity and tolerance in the intestinal epithelium of Jamaican Fruit Bats
牙买加果蝠肠上皮的抗病毒免疫和耐受机制
- 批准号:
10592671 - 财政年份:2023
- 资助金额:
$ 35.33万 - 项目类别:
The role of the gut microbiome in ICB-induced anti-tumor response and toxicity
肠道微生物组在 ICB 诱导的抗肿瘤反应和毒性中的作用
- 批准号:
10606715 - 财政年份:2023
- 资助金额:
$ 35.33万 - 项目类别:
Mechanism of immune response to muscle-directed AAV gene transfer
肌肉定向 AAV 基因转移的免疫反应机制
- 批准号:
10717750 - 财政年份:2023
- 资助金额:
$ 35.33万 - 项目类别:
Regulation of RNA sensing and viral restriction by RNA structures
RNA 结构对 RNA 传感和病毒限制的调节
- 批准号:
10667802 - 财政年份:2023
- 资助金额:
$ 35.33万 - 项目类别: